CADTH
  • Home
  • Contact Us
  • Advanced Search
  • Sitemap
  • Extranet
  • Help
  •  
  • Français
  • About
    CADTH
    • Corporate Profile
    • CADTH Products
    • Therapeutic Review
    • Contact Us
    • Terms of Use
  • Knowledge
    Exchange
    • Knowledge Transfer
    • Liaison Program
    • Partnerships and Strategic Initiatives
  • Health Technology
    Assessment
    • HTA News
    • HTA Reports and Publications
    • Programs
    • HTA Projects
    • HTA Events
    • Advisory Committees
    • FAQ
    • Suggest a Topic
    • Contact Us
  • Common Drug
    Review
    • CDR Overview
    • CDR Process
    • Advisory Committees
    • Recommendations and Status of Drug Submissions
    • Search CDR Drug Database
    • CDR Update
    • Filing a Submission
    • CDR Links
    • CDR News
    • Events
    • Contact Us
  • Canadian Optimal Medication
    Prescribing & Utilization Service
    • Search Our Publications and Tools
    • Insulin Analogue Therapy
    • Blood Glucose Test Strips
    • Second-line therapy for patients with diabetes
    • Rx for Change Database
    • Proton Pump Inhibitor Therapy
    • Optimal Therapy Resources
    • COMPUS Communiqué
    • About COMPUS
    • Advisory Committees
    • COMPUS Process
    • Contact Us
  • Policy
    Forum
    • Policy Options Documents
    • Policy Information Documents
    • Discussion Papers
    • HTIS reports commissioned by Policy Forum
    • Terms of Reference
    • Member Listing
    • Contacts
  • Media Centre
  • Events
  • Careers
  • Subscribe
  • Related Links
  • CADTH @ 20

Search

Advanced Search

What is this?

Related searches to: Intra-

Suggested subject headings
  • Intra-Abdominal Fat
What is this?

Results 1 - 10 of 13 for "Intra-"

Next »1 2

  1. TomoTherapy, Gamma Knife, and CyberKnife Therapies for Patients with Tumours of the Lung, Central Nervous System, or Intra-abdomen: A Systematic Review of Clinical Effectiveness and Cost-Effectiveness

    Technology Reports

    September 16, 2009

    Context and Policy Issues Stereotactic radiosurgery (SRS) and stereotactic radiotherapy, which deliver high doses of radiation to tumour sites, are used to stop the division of tumour cells. Three such therapies are TomoTherapy, Gamma Knife surgery (GKS), and CyberKnife surgery (CKS). SRS ref...
    View Summary | View Report
  2. FAQ
    What is the HEALTH Technology Inquiry Service (HTIS)? The HTIS is a service offered by the Canadian Agency for Drugs and Technologies in Health (CADTH) to provide Canadian health care decision makers with quick access to health technology assessment (HTA) information. The HTIS is one example of how...
  3. Research and Practice
    These reports are available without cost at the websites below: CADTH HTAs Long-Acting Beta2-Agonist and Inhaled Corticosteroid Combination Therapy for Adult Persistent Asthma: Systematic Review of Clinical Outcomes and Economic Evaluation. CADTH, November 2009:  http://www.cadth.ca/medi...
  4. New and Emerging Health Technology Reports
    Recent Reports from CADTH and Other HTA AgenciesThese reports are available without cost at the web sites shown below:Agence d’évaluation des technologies et des modes d’intervention en santé (AÉTMIS)Three-wheel and four-wheel scooters: alternatives to powered wheelc...
  5. Overview of Clinical and Cost-Effectiveness of Prostaglandin Analogues for Ophthalmic Use
    Issue 30

    Technology Overviews

    June 26, 2007

    Overview of Clinical and Cost-Effectiveness of Prostaglandin Analogues for Ophthalmic UseTechnology and Condition Prostaglandin analogues (PGAs) in the treatment of elevated intraocular pressure (IOP): bimatoprost, latanoprost, and travoprost Issue PGAs are more costly than alternative agents for th...
    View Summary | View Report
  6. Prostaglandin Analogues for Ophthalmic Use: Analysis of Clinical and Cost-Effectiveness
    Issue 89

    Technology Reports

    June 26, 2007

    Technology and Condition Prostaglandin analogues (PGAs) in the treatment of elevated intraocular pressure (IOP): bimatoprost, latanoprost, and travoprost Issue PGAs are more costly than alternative agents for the lowering of IOP. One policy decision to be made is whether reimbursement of these agent...
    View Summary | View Report
  7. Impact Evaluation
    Introduction The principles of evidence-based medicine dictate that the best available evidence should be used to guide clinical choices (Dawes et al. 1999). It has been argued that the same standard should be applied to educational interventions to improve practice (Oxman et al. 1995, Grimshaw ...
  8. Appendix 10b : ADUP Internal Evaluation (Academic Detailing) : (Behavioural Change) Initiative - Osteoporosis
    ALBERTA MANAGEMENT COMMITTEE ON DRUG UTILIZATION / ALBERTA DRUG UTILIZATION PROGRAMINTERNAL EVALUATION - ACADEMIC DETAILING (BEHAVIORAL CHANGE) INITIATIVE – OSTEOPOROSISPrepared by Harold LopatkaEXECUTIVE SUMMARYAn internal evaluation of the behavioral change (academic detailing) initiative ...
  9. Intra-Articular Hyaluronic Acid (Viscosupplementation) for Hip Osteoarthritis
  10. New and Emerging Health Technology Reports
    Recent Reports from CADTH and Other HTA AgenciesPrevious issues of Health Technology UpdateCADTHThese reports are available without cost at the web sites shown below:Australia and New Zealand Horizon Scanning Network (ANZHSN) Primer and probe set for the diagnosis of avian influenzaAvailable:http://...

Next »1 2

Top of Page Privacy Policy Feedback Terms of use

© 2010 Canadian Agency for Drugs and Technologies in Health

Last Updated February 28, 2006